Assessing Safety of Direct Thrombin Inhibitors, Direct Factor Xa Inhibitors and Vitamin K Antagonists in Patients with Atrial Fibrillation: A Nation-Wide Propensity Score Matched Cohort from Sweden.

Linder, Marie; Iliadou Nyman, Anastasia; Kieler, Helle; Danielsson, Bengt; Borg, Natalia; Gry, Marcus; Collin, Julius

Linder, Marie; Iliadou Nyman, Anastasia; Kieler, Helle; Danielsson, Bengt; Borg, Natalia; Gry, Marcus; Collin, Julius.

Afiliación

Linder M; Centre for Pharmacoepidemiology, Karolinska Institutet, T2, Karolinska University Hospital, Stockholm, Sweden.
Iliadou Nyman A; The National Board of Health and Welfare, Stockholm, Sweden.
Kieler H; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Danielsson B; Centre for Pharmacoepidemiology, Karolinska Institutet, T2, Karolinska University Hospital, Stockholm, Sweden.
Borg N; The National Board of Health and Welfare, Stockholm, Sweden.
Gry M; The National Board of Health and Welfare, Stockholm, Sweden.
Collin J; The National Board of Health and Welfare, Stockholm, Sweden.

Clin Epidemiol ; 12: 1029-1038, 2020.

Article en En | MEDLINE | ID: mdl-33116897

Palabras clave

anticoagulants; arrhythmia; epidemiology; safety

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Epidemiol Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google